Skip to content
10-Q/A

Quarterly Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001549727-17-000020

← back to feed
Filed
Apr 11, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Mar 13, 2017 81.5M sh
Operating Cash Flow restated Q2 2017 · Dec 31, 2016 −$22.97K
Operating Cash Flow Q2 2017 · Dec 31, 2015 −$125.15K
Cash And Equivalents restated Q2 2017 · Dec 31, 2016 $6.34K
Cash And Equivalents Q2 2017 · Jun 30, 2016 $29.31K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $28.62K
Cash And Equivalents Q2 2017 · Jun 30, 2015 $13.77K
Stockholders Equity restated Q2 2017 · Dec 31, 2016 −$63.41K
Stockholders Equity Q2 2017 · Jun 30, 2016 −$11.96K
Current Liabilities restated Q2 2017 · Dec 31, 2016 $93.52K
Current Liabilities Q2 2017 · Jun 30, 2016 $75.92K
Current Assets restated Q2 2017 · Dec 31, 2016 $27.11K
Current Assets Q2 2017 · Jun 30, 2016 $53.47K
Total Assets restated Q2 2017 · Dec 31, 2016 $30.11K
Total Assets Q2 2017 · Jun 30, 2016 $63.96K
Sga Expense restated Q2 2017 · Dec 31, 2016 $12.39K
Sga Expense restated Q2 2017 · Dec 31, 2016 $52.91K
Sga Expense Q2 2017 · Dec 31, 2015 $39.42K
Sga Expense Q2 2017 · Dec 31, 2015 $107.76K
Net Income restated Q2 2017 · Dec 31, 2016 −$12.3K
Net Income restated Q2 2017 · Dec 31, 2016 −$51.45K
Net Income Q2 2017 · Dec 31, 2015 −$34.69K
Net Income Q2 2017 · Dec 31, 2015 −$97.55K
Gross Profit restated Q2 2017 · Dec 31, 2016 $91
Gross Profit restated Q2 2017 · Dec 31, 2016 $1.46K
Gross Profit Q2 2017 · Dec 31, 2015 $4.73K
Gross Profit Q2 2017 · Dec 31, 2015 $10.21K
Cost Of Revenue restated Q2 2017 · Dec 31, 2016 $272
Cost Of Revenue restated Q2 2017 · Dec 31, 2016 $4.39K
Cost Of Revenue Q2 2017 · Dec 31, 2015 $9.18K
Cost Of Revenue Q2 2017 · Dec 31, 2015 $21.97K
Revenue Q2 2017 · Dec 31, 2016 $363
Revenue Q2 2017 · Dec 31, 2016 $5.85K
Revenue Q2 2017 · Dec 31, 2015 $13.91K
Revenue Q2 2017 · Dec 31, 2015 $32.19K